The Stryker Corporation is prepared to issue yet another hip implant recall after receiving a higher than expected number of complaints over its LFIT V40 femoral heads. These devices are known to be widely used on both Accolade TMZF and Accolade 2 stems, as well as Meridian and Citation stems.
Free Confidential Lawsuit Evaluation: If you or a loved one suffered complications from hip replacement surgery, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
Update: New Jersey Supreme Court Establishes MCL for Stryker LFIT Lawsuits
June 5, 2017 – The New Jersey Supreme Court has approved a request to consolidate state lawsuits filed by plaintiffs alleging complications from the Stryker LFIT Anatomic Cobalt Chromium V40 Femoral Head. The request follows a bid for multidistrict litigation (MDL) status in January by the U.S. Judicial Panel on Multidistrict Litigation (JPML).
What’s the Problem?
October 5, 2016 – Last week, Australia’s Therapeutic Goods Administration (TGA) issued a hazard alert after Stryker received a higher than expected number of complaints of taper lock for specific lots of the following sizes of LFIT Anatomic CoCr V4·0TM Femoral Heads manufactured prior to 2011:
Catalog Number Head Diameter Offset
6260-9-236 36mm +5
6260-9-240 40mm +4
6260-9-244 44mm +4
6260-9-340 40mm +8
6260·9-440 40mm +12
6260-9-344 44mm +8
6260-9-444 44mm +12
Hip Replacement Complications
Failure of a Stryker LFIT V40 femoral head may result in one or more of the following complications:
- Loss of mobility
- Adverse local tissue reaction (ALTR)
- Joint instability
- Broken bones around the hip implant
- Leg length discrepancy
- The need for revision surgery
Australian health regulators urged patients who received a Stryker LFIT V40 femoral head to be aware of the problems and consult their physician if they have any questions. They also said patients should seek immediate medical attention if they experienced any unexpected pain, loss of mobility, inflammation, instability or other problems that could be associated with a defective hip replacement device.
Will the FDA Issue a Recall?
It is unknown at this time whether the U.S. Food & Drug Administration (FDA) will issue similar warnings to those in Australia, or require Stryker to recall the LFIT V40 femoral head. However, In July 2012 the company recalled the Rejuvenate and ABG II hip implants over similar safety concerns. Lawsuits filed over those devices were later consolidated into a multidistrict litigation (MDL No. 13-2441) in the U.S. District Court for the District of Minnesota.
MDL Court Schedules Initial Conference in LFIT V40 Litigation
April 28, 2017 – The Stryker LFIT MDL is about to get underway, with the proceeding’s Initial Status Conference scheduled for May 16, 2017 at 3:00 p.m. Topics to be addressed include Plaintiffs’ leadership structure, potential objectives for the litigation, and the scheduling of upcoming status conferences.
LFIT V40 Femoral Head Lawsuits Consolidated in Massachusetts
April 10, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has transferred dozens of lawsuits alleging injuries from hip replacement systems featuring Stryker LFIT V40 femoral heads into the U.S. District Court, District of Massachusetts, as part of a multidistrict litigation (MDL). JPML announced its decision Wednesday, consenting to a petition filed by patients who claim that Stryker LFIT Anatomic CoCr V40 femoral heads are defective.
Massachusetts Woman Sues Over Complications from Stryker LFIT Femoral Head
March 29, 2017 – A woman from Massachusetts who allegedly suffered metallosis and trunnionosis (corrosion) in her hip joint from a defective LFIT V40 femoral head has filed a products liability lawsuit against Stryker Corp. These complications required the plaintiff to endure extensive painful rehabilitation, and she is charging Stryker with designing an allegedly defective medical device in the Stryker LFIT V40 femoral head.
Federal Stryker LFIT V40 Lawsuits May Be Consolidated into MDL
February 23, 2017 – Plaintiffs’ lawyers have requested multidistrict litigation (MDL) status for lawsuits involving the Stryker LFIT Anatomic Cobalt Chromium V40 Femoral Head. They are recommending the District of Massachusetts for the MDL because it provides an easily accessible location, the venue can handle a high volume of cases, and it has very experienced judges.
Alaska Couple Files Stryker LFIT V40 Lawsuit
February 15, 2017 – A couple from Alaska has filed a products liability lawsuit against Stryker Corp. over injuries alleged from the LFIT V40 hip implant. According to the lawsuit, problems with the Accolade TMZF femoral stem and LFIT V40 Head forced the Plaintiff to undergo painful hip revision surgery, during which the surgeons found multiple complications associated with the components.
Lawyers Request MCL for Stryker LFIT Litigation
February 13, 2017 – Plaintiffs lawyers are seeking multicounty litigation (MCL) status in New Jersey for lawsuits alleging injuries from the Stryker LFIT Anatomic Cobalt Chromium V40 Femoral Head. The proposed venue for the litigation is Bergen County, where at least 25 cases are currently pending. Court records indicate that filings have recently increased, with at least 85 cases filed in courts across the U.S.
Do I Have a Stryker LFIT V40 Hip Implant Lawsuit?
The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Stryker LFIT V40 Hip Implant lawsuits. We are handling individual litigation nationwide and currently accepting new injury cases in all 50 states.
Free Case Evaluation: Again, if you were injured by a Stryker hip implant, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.